People with two types of cancers who need treatment costing millions of New Taiwan dollars are now covered by the National Health Insurance (NHI) system.
From Nov. 1, people with B-cell acute lymphoblastic leukemia (B-ALL), one of the most common types of childhood cancer, or relapsed or refractory diffuse large B-cell lymphoma (DLBCL) are covered if they meet certain criteria, the National Health Insurance Administration (NHIA) announced last month.
The therapy for people with these cancers takes T cells and modifies them with chimeric antigen receptors (CARs) so that they can recognize and destroy cancer cells.
Photo: CNA
It costs about NT$8.19 million (US$253,537), said Huang Yu-wen (黃育文), director of the NHIA’s Medical Review and Pharmaceutical Benefits Division.
Given the cost, the NHIA has limited coverage to two types of cancer patients and a period of up to two years, but discussions are to be held to decide if the coverage should last longer, NHIA Director-General Shih Chung-liang (石崇良) said.
The Food and Drug Administration previously approved the use of CAR T cell therapy for all people with B-ALL aged 25 or under and for people with DLBCL whose cancers have relapsed or not responded to first or second-line treatments.
To be eligible for NHI coverage under the new program, people with B-ALL must be aged 25 or under, have leukemia that has not responded to other treatments, have relapsed after a bone marrow transplant or have had more than one relapse.
People with DLBCL are eligible for coverage if their cancer has recurred or not responded to treatments considered to be second-line or higher.
Huang Wei-han (黃威翰), deputy director of Hualien Tzu Chi Hospital’s Cell Therapy Center, said that 15 to 20 percent of young people with B-ALL have relapses, and only 30 to 50 percent of those who have relapses survive for five years.
About half of adult cases relapse, and only 10 percent of them survive for five years, he said.
Last year, a 10-year-old girl who had been battling B-ALL for more than four years became the first person in Taiwan to be successfully treated using CAR T cell therapy, Huang said.
Meanwhile, bone marrow transplants do not work for roughly half of all people with DLBCL, and those diagnosed with a cancer that has not responded to treatment or whose cancer has relapsed after a bone marrow transplant have only a 20 percent chance of surviving for two years, he said.
Huang Tai-chung (黃泰中), an attending hematology physician at National Taiwan University Hospital and secretary-general of the Hematology Society of Taiwan, said that 40 percent of people with DLBCL become completely cancer free after receiving CAR T cell treatment, while 13 percent are partially cured.
“Even if their cancer is only partially cured, it means a lot to the patients,” because it can help prepare them for the next stage of treatment, he said.
Sixty percent of people with B-ALL whose bone marrow transplants have failed can be completely cured with CAR T cell treatment, Huang Tai-chung said.
People can receive CAR T cell treatment at seven hospitals in Taiwan: National Taiwan University Hospital, National Taiwan University Cancer Center, Linkou Chang Gung Memorial Hospital, China Medical University Hospital, Taichung Veterans General Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital and Hualien Tzu Chi Hospital, Shih said.
The Taipei Zoo on Saturday said it would pursue legal action against a man who was filmed climbing over a railing to tease and feed spotted hyenas in their enclosure earlier that day. In videos uploaded to social media on Saturday, a man can be seen climbing over a protective railing and approaching a ledge above the zoo’s spotted hyena enclosure, before dropping unidentified objects down to two of the animals. The Taipei Zoo in a statement said the man’s actions were “extremely inappropriate and even illegal.” In addition to monitoring the hyenas’ health, the zoo would collect evidence provided by the public
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
A road safety advocacy group yesterday called for reforms to the driver licensing and retraining system after a pedestrian was killed and 15 other people were injured in a two-bus collision in Taipei. “Taiwan’s driver’s licenses are among the easiest to obtain in the world, and there is no mandatory retraining system for drivers,” Taiwan Vision Zero Alliance, a group pushing to reduce pedestrian fatalities, said in a news release. Under the regulations, people who have held a standard car driver’s license for two years and have completed a driver training course are eligible to take a test
‘SIGN OF DANGER’: Beijing has never directly named Taiwanese leaders before, so China is saying that its actions are aimed at the DPP, a foundation official said National Security Bureau (NSB) Director-General Tsai Ming-yen (蔡明彥) yesterday accused Beijing of spreading propaganda, saying that Chinese President Xi Jinping (習近平) had singled out President William Lai (賴清德) in his meeting with US President Joe Biden when talking about those whose “true nature” seek Taiwanese independence. The Biden-Xi meeting took place on the sidelines of the APEC summit in Peru on Saturday. “If the US cares about maintaining peace across the Taiwan Strait, it is crucial that it sees clearly the true nature of Lai and the ruling Democratic Progressive Party (DPP) in seeking Taiwanese independence, handles the Taiwan question with extra
RSS